p38 Mitogen‐activated protein kinase and PI3‐kinase are involved in up‐regulation of mu opioid receptor transcription induced by cycloheximide
Open Access
- 27 December 2010
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 116 (6) , 1077-1087
Abstract
J. Neurochem. (2011)116, 1077–1087. Despite several decades of efforts to develop safer, efficacious, and non‐addictive opioids for pain treatment, morphine remains the most valuable painkiller in contemporary medicine. Morphine and endogenous mu opioid peptides exert their pharmacological actions mainly through the mu opioid receptor (MOR). Analgesic effects of opioids in animals are dependent on the MOR expression levels, as demonstrated by studies of MOR‐knockout mice (homo/heterozygotes) and MOR‐less expressing mice. Surprisingly, in the course of our investigation to understand the mechanisms involved in the regulation of MOR gene expression, cycloheximide (CHX), a known protein synthesis inhibitor, markedly induced accumulation of MOR mRNAs in both MOR‐negative and ‐positive cells. This induction was blocked by inhibitors of phosphoinositide 3‐kinase (PI3‐K) and p38 MAPK, but not by a p42/44 MAPK inhibitor.In vitro, CHX was found to activate the MOR promoter and this activation was suppressed by inhibition of PI3‐K. The transcriptional activator Sox18 was recruited to the MOR promoter in CHX‐treated cells and this recruitment was also inhibited by the PI3‐K and p38 MAPK inhibitors, Ly294002 and SB203580, respectively. Consistently, acetylation of histone H3 and induction of H3‐K4 methylation were detected while reductions of histone deacetylase 2 binding and H3‐K9 methylation were observed on the promoter. Furthermore, the MOR mRNA accumulation was almost completely inhibited in the presence of actinomycin‐D, indicating that this effect occurs mainly through activation of the transcriptional machinery. These observations suggest that CHX directly induces MOR gene transcription by recruiting the active transcription factor Sox18 to the MOR promoter through PI3‐ and/or p38 MAPK pathways.Keywords
This publication has 51 references indexed in Scilit:
- Up-Regulation of the μ-Opioid Receptor Gene Is Mediated through Chromatin Remodeling and Transcriptional Factors in Differentiated Neuronal CellsMolecular Pharmacology, 2010
- The Protein Synthesis Inhibitor Anisomycin Induces Macrophage Apoptosis in Rabbit Atherosclerotic Plaques through p38 Mitogen-Activated Protein KinaseThe Journal of Pharmacology and Experimental Therapeutics, 2009
- A Proteomics Approach for Identification of Single Strand DNA-binding Proteins Involved in Transcriptional Regulation of Mouse μ Opioid Receptor GeneMolecular & Cellular Proteomics, 2008
- Protein synthesis inhibitors, gene superinduction and memory: Too little or too much protein?Neurobiology of Learning and Memory, 2008
- Evidence of Endogenous Mu Opioid Receptor Regulation by Epigenetic Control of the PromotersMolecular and Cellular Biology, 2007
- Translational repression of mouse mu opioid receptor expression via leaky scanningNucleic Acids Research, 2007
- Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) geneNucleic Acids Research, 2006
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Protein Synthesis Inhibitors Cycloheximide and Anisomycin Induce Interleukin-6 Gene Expression and Activate Transcription Factor NF-κBBiochemical and Biophysical Research Communications, 1997
- Superinduction of NF-κB by Actinomycin D and Cycloheximide in Epithelial CellsBiochemical and Biophysical Research Communications, 1996